Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Vedolizumab biosimilar by Polpharma Biologics for Ulcerative Colitis: Likelihood of Approval
Vedolizumab biosimilar is under clinical development by Polpharma Biologics and currently in Phase III for Ulcerative Colitis. According to GlobalData,...